We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$204M
AUM Growth
+$15.9M
Cap. Flow
+$17.5M
Cap. Flow %
8.58%
Top 10 Hldgs %
6.14%
Holding
488
New
66
Increased
245
Reduced
135
Closed
40

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$976K
2
NFLX icon
Netflix
NFLX
+$953K
3
CRWD icon
CrowdStrike
CRWD
+$952K
4
RCL icon
Royal Caribbean
RCL
+$905K
5
TJX icon
TJX Companies
TJX
+$890K

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$1.11M
2
LLY icon
Eli Lilly
LLY
+$937K
3
FCX icon
Freeport-McMoran
FCX
+$933K
4
ALGN icon
Align Technology
ALGN
+$933K
5
MLM icon
Martin Marietta Materials
MLM
+$930K

Sector Composition

Rank Sector Weight
1 Financials 26.66%
2 Healthcare 19.14%
3 Technology 17.16%
4 Energy 7.21%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYTM icon
226
Rhythm Pharmaceuticals
RYTM
$7.39B
$305K 0.15%
7,423
-1,451
-16% -$57.9K
AGIO icon
227
Agios Pharmaceuticals
AGIO
$2.26B
$304K 0.15%
7,042
-9,353
-57% -$338K
LXRX icon
228
Lexicon Pharmaceuticals
LXRX
$1.03B
$302K 0.15%
179,972
-113,120
-39% -$203K
APLS
229
DELISTED
Apellis Pharmaceuticals
APLS
$297K 0.15%
7,738
+436
+6% +$19.7K
ZLAB icon
230
Zai Lab
ZLAB
$2.12B
$290K 0.14%
16,727
+4,114
+33% +$72.3K
BBIO icon
231
BridgeBio Pharma
BBIO
$16.6B
$288K 0.14%
11,357
+746
+7% +$20.4K
GERN icon
232
Geron
GERN
$956M
$286K 0.14%
67,490
+28,285
+72% +$110K
ONC
233
BeOne Medicines Ltd
ONC
$34B
$282K 0.14%
1,979
-52
-3% -$8.01K
IMCR icon
234
Immunocore
IMCR
$1.77B
$281K 0.14%
8,298
+2,336
+39% +$119K
NVAX icon
235
Novavax
NVAX
$1.26B
$277K 0.14%
21,884
+6,656
+44% +$67K
BNTX icon
236
BioNTech
BNTX
$23.2B
$276K 0.14%
3,431
-234
-6% -$21.4K
PTCT icon
237
PTC Therapeutics
PTCT
$6.35B
$273K 0.13%
8,925
-4,880
-35% -$158K
CRSP icon
238
CRISPR Therapeutics
CRSP
$4.66B
$273K 0.13%
5,047
-1,007
-17% -$58.2K
TARS icon
239
Tarsus Pharmaceuticals
TARS
$2.65B
$270K 0.13%
9,938
-9,990
-50% -$336K
MRNA icon
240
Moderna
MRNA
$22.3B
$269K 0.13%
2,268
-2,169
-49% -$274K
ESPR
241
DELISTED
Esperion Therapeutics
ESPR
$251K 0.12%
+113,178
New +$266K
ARLP icon
242
Alliance Resource Partners
ARLP
$3.28B
$222K 0.11%
9,085
+6
+0.1% +$136
CWEN icon
243
Clearway Energy Class C
CWEN
$5.01B
$211K 0.1%
8,547
+1,828
+27% +$46.2K
GPRK icon
244
GeoPark
GPRK
$622M
$209K 0.1%
19,079
-1,518
-7% -$15.2K
WES icon
245
Western Midstream Partners
WES
$19.3B
$206K 0.1%
5,197
-1,224
-19% -$45K
CPT icon
246
Camden Property Trust
CPT
$11.2B
$202K 0.1%
1,847
+7
+0.4% +$723
EXR icon
247
Extra Space Storage
EXR
$31.3B
$201K 0.1%
1,296
-5,022
-79% -$732K
NSA
248
DELISTED
National Storage Affiliates Trust
NSA
$201K 0.1%
4,866
+463
+11% +$17.5K
ADC icon
249
Agree Realty
ADC
$9.73B
$199K 0.1%
3,212
+336
+12% +$19.9K
IIPR icon
250
Innovative Industrial Properties
IIPR
$1.78B
$199K 0.1%
1,820
+7
+0.4% +$735
8 9
10
11 12

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Virtus ETF Advisers held 488 positions worth $204M, up 8.5% from $188M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $17.5M of net new capital in Q2 2024, opening 66 new positions and adding to 245 existing holdings. Its largest new stake was Qualcomm: 5,165 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Extra Space Storage, an estimated $732K trimmed.

  • Virtus ETF Advisers's largest Q2 2024 buy was Qualcomm: 5,165 shares worth $1.03M.
  • Virtus ETF Advisers added most to EOG Resources in Q2 2024, an estimated $789K increase.
  • Virtus ETF Advisers's biggest Q2 2024 reduction was Extra Space Storage, cutting an estimated $732K.
  • Virtus ETF Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.11M.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $204M portfolio in Q2 2024.
  • Virtus ETF Advisers opened 66 new positions and closed 40 in Q2 2024.
  • Virtus ETF Advisers's portfolio value rose 8.5% quarter-over-quarter to $204M.

Based on Virtus ETF Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.